PHGDH and glioblastoma: Our results also demonstrate that targeting GSCs through either genetic deletion or pharmacological inhibition of PHGDH effectively suppresses GBM growth and mitigates resistance to radiation therapy, highlighting that PHGDH blockade may synergize with radiotherapy in the treatment of GBM.